Skip to content

Insmed INSM Goodwill

Goodwill at other companies

United Therapeutics logo
United TherapeuticsUTHR
$115.5M+3.4%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$62.48M+3.0%
Rein Therapeutics Inc. logo
Rein Therapeutics Inc.RNTX
$6.33M0.0%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$17.91M0.0%
Mannkind logo
MannkindMNKD
$67.6M+3,401%

Other financials

Income statement

See full
Revenue$306.0M+230%
Gross profit$258.5M+261%
Operating income-$153.3M+38.2%
Net income-$163.6M+36.3%
EPS (diluted)-$0.76+46.5%

Balance sheet

See full
Cash & equivalents$582.2M+44.4%
Total debt$580.3M-49.2%
Total equity$704.9M+611%
Total assets$2.1B+15.2%

Cash flow

See full
Operating cash flow-$222.7M+15.0%
CapEx$3.5M-65.4%
Free cash flow-$226.2M+16.9%

Valuation

See full
Market cap$23.11B+17.6%
Enterprise value$23.11B+22.0%
P/S28.2×-21.1×

Profitability

See full
Gross margin81.8%+5.3pp
Operating margin-140.6%-43.9pp
Net margin-144.4%-45.3pp
FCF margin-112.5%-35.3pp

Returns & leverage

See full
Return on equity-294.5%
Debt / equity0.8×-10.7×
Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insmed's goodwill?
Insmed (INSM) reported goodwill of $136.11M in Q1 2026.
How has Insmed's goodwill changed year-over-year?
Insmed's goodwill decreased by 0.0% year-over-year, from $136.11M to $136.11M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.